AH Bio Fund I, L.P. → Freenome, Inc. FRNM

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (5.6 DTC)
Short interest building (+31.9% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 5.58

4,483,175 shares short · +31.9% vs prior

Other 13D/G Filings on Freenome, Inc.

Filed	Form	Filer	Stake	Shares
2026-09-01	SCHEDULE 13G	ROCHE HOLDINGS INC	—	—	view →
2026-07-23	SCHEDULE 13G	PERCEPTIVE ADVISORS LLC	—	—	view →
2026-07-22	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	15,367,270	view →
2026-07-08	SCHEDULE 13G	Point72 Asset Management, L.P.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →